Addiction Treatment Telehealth | SUD Telehealth Technology | Qventive
Qventive Healthcare

Addiction Treatment Telehealth Technology

Addiction treatment telehealth has expanded dramatically since COVID-era DEA flexibilities enabled telehealth MAT prescribing — buprenorphine telehealth initiation, telehealth group therapy, virtual individual counseling, and 42 CFR Part 2 compliance in telehealth context. Current DEA rules continue evolving. Qventive handles SUD telehealth with attention to regulatory compliance and operational requirements.

Why Addiction Treatment Telehealth Tech Can't Wait

There are two kinds of IT companies that handle addiction treatment telehealth technolog: those that learned it from a vendor webinar, and those that learned it by sitting beside physicians during patient encounters for 30 years. Qventive is the second kind.

When addiction treatment telehealth tech isn’t handled by healthcare-specific experts, the consequences compound. Addiction treatment facilities face dual compliance pressure — HIPAA for general healthcare records and 42 CFR Part 2 for substance use disorder records. A single misconfigured EHR permission can expose protected SUD records to unauthorized staff or external systems.

Addiction Treatment Practice Technology

Addiction Treatment practices operate under specific documentation standards, diagnostic workflows, and compliance requirements. Our team has configured technology for dozens of addiction treatment practices across Northern New Jersey.

🔄

Addiction Treatment EHR Configuration

We work with Kipu Health, Sunwave Health, BestNotes — specialty templates, order sets, and reporting dashboards configured for addiction treatment clinical patterns.

📋

Regulatory Requirements

42 CFR Part 2 + HIPAA dual compliance for SUD records. Technology configured to support these obligations without adding documentation time to your providers’ day.

Clinical Workflow Design

Intake and assessment documentation, medication-assisted treatment (MAT) tracking, group therapy session logging, urine drug screen result integration, and discharge planning workflows. We observe before configuring — because every addiction treatment practice operates slightly differently.

Turning Addiction Treatment Telehealth Tech Challenges Into Measurable Wins

Three principles guide every addiction treatment telehealth tech engagement:

Depth over breadth. We serve one industry. That means our engineers spend their entire careers learning healthcare workflows, EHR platforms, and compliance frameworks — not splitting attention across retail, legal, and finance.

Evidence over assumptions. We observe your practice before configuring anything. Most implementations fail because someone assumed they understood the workflow. We don’t assume.

Prevention over repair. Any IT company can fix things after they break. We monitor 24/7 to catch issues before your team even notices them. That’s the difference between reactive support and proactive partnership.

Addiction Treatment Practice — EHR Workflow Optimization
THE PROBLEM
A addiction treatment practice was losing 30+ minutes per provider per day to poorly configured EHR templates. Intake and assessment documentation required manual workarounds that the generic EHR setup couldn’t handle.
THE SOLUTION
Qventive’s EHR analysts redesigned specialty-specific templates, configured Kipu Health integration points, and retrained clinical staff on optimized documentation workflows using our Observe-Improve-Prevent methodology.
THE RESOLUTION
Documentation time decreased by 35 minutes per provider per day within 30 days. Staff satisfaction scores improved as click-heavy workarounds were eliminated. The practice now captures quality measure data at the point of care for MIPS reporting.

Ready to Talk?

30-minute assessment. No pitch.

Resources

SUD Telehealth Domains

Five operational domains.

Telehealth MAT prescribing

Buprenorphine (Suboxone, Zubsolv, Sublocade) telehealth initiation enabled by DEA flexibilities — substantial expansion of MAT access. Current DEA rules continue evolving; practices must track latest guidance. State-specific rules may impose additional requirements beyond federal baseline. For Sublocade (long-acting injectable buprenorphine), administration requires in-person visit to healthcare provider; telehealth covers prescribing decision-making. See our addiction treatment practice management page.

Telehealth group therapy

SUD group therapy via HIPAA-compliant video platforms. Group therapy billing (CPT 90853) applies with specific documentation (group census, session content, individual participation). Platform selection for multi-participant sessions matters — not all behavioral health platforms support high-quality multi-participant video. Technology, connectivity, and patient engagement considerations.

42 CFR Part 2 compliance

Part 2 protections apply fully in telehealth context. Telehealth platform must support Part 2-compliant record handling, consent workflow, and access controls. Video recording (if any) subject to Part 2 protections. See our 42 CFR Part 2 page.

Toxicology challenges in telehealth

Urine drug testing requires in-person specimen collection. Telehealth-only programs use various approaches — periodic in-person visits for UDT, patient-collected samples with chain-of-custody concerns, observed testing via video (clinical and legal questions), or laboratory partnership for local specimen collection. Telehealth-only SUD programs have challenge around UDT; hybrid models typically more defensible.

Hybrid care models

Most SUD programs now operate hybrid — telehealth for individual therapy and some medication management, in-person for initial evaluation, toxicology, and specific treatments. Hybrid models balance access (telehealth reduces barriers) with clinical appropriateness (in-person for what requires it).

Addiction Treatment Telehealth Tech: Straight Answers

Yes, under current DEA rules (which continue evolving). COVID-era flexibilities enabling telehealth buprenorphine initiation have been repeatedly extended; DEA has moved toward permanent framework. Current DEA guidance must be tracked — rules have changed multiple times. State laws add additional requirements (some states require in-person evaluations beyond federal baseline). DEA Diversion Control. See our addiction treatment practice management page.
Yes. HIPAA-compliant multi-participant video platforms support SUD group therapy. Group therapy billing (CPT 90853) applies with standard documentation requirements (group size, session content, individual participation). Platform selection matters — not all telehealth platforms handle multi-participant video well. Some patients engage better in telehealth groups; some benefit from in-person presence. Hybrid models common.
Part 2 protections apply fully in telehealth context. Telehealth infrastructure must support Part 2-compliant record handling (access controls, consent workflow, audit logging, redisclosure restrictions). Video platforms must have appropriate BAAs and Part 2 considerations. Any video recording (generally not recommended for SUD treatment) would be subject to Part 2 protections. See our 42 CFR Part 2 page.
Significant challenge. UDT requires in-person specimen collection for reliable chain of custody. Telehealth-only SUD programs use various approaches: periodic in-person visits specifically for UDT, partnership with labs for local specimen collection, patient-collected samples (questionable chain of custody), or observed testing via video (raises clinical and practical questions). Hybrid models with in-person UDT typically more defensible from both clinical and billing audit perspectives.
Very limited. Methadone for opioid use disorder requires SAMHSA-licensed OTP under 42 CFR Part 8. Telehealth expansion in OTPs has occurred for some components (counseling, team conferences) but dosing remains in-person. OTPs cannot generally operate primarily via telehealth. This is structural not just current practice — methadone regulatory framework is more restrictive than buprenorphine.
Sublocade (long-acting injectable buprenorphine, monthly administration) requires in-person visit to healthcare provider for administration. Telehealth covers decision-making, patient selection, ongoing management, and coordination; actual injection requires provider-administered in-office visit. Some programs have nurse-administered Sublocade at home but this has specific regulatory and logistical considerations.
Yes. Addiction treatment telehealth has substantial PE activity — platforms include Bicycle Health, Workit Health, Boulder Care, Ophelia, and others focused on telehealth MAT. Traditional addiction treatment programs increasingly operate hybrid models. Our PE practice supports addiction treatment platforms including telehealth components.
Get In Touch

Ready to Modernize Your Practice Technology?

Schedule your free practice technology assessment. Our healthcare IT specialists will review your current systems, identify gaps, and outline a roadmap built specifically for your practice.

  • 30 years of healthcare-only experience
  • EHR-certified across 7 major platforms
  • HIPAA-compliant from day one
  • No long-term contracts required
Book Your Free Assessment
Last Updated: April 2026  ·  Reviewed by: Qventive Healthcare clinical technology team

Stop refereeing IT vendors.
Start growing your practice.

Free assessment. No obligation.

Let’s Meet 📞 (201) 488-2750